Conference
2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma
Authors
Petrylak DP; Tagawa ST; Kohli M; Eisen A; Canil C; Sridhar SS; Spira A; Yu EY; Burke JM; Shaffer D
Volume
51
Publisher
Elsevier
Publication Date
September 1, 2015
DOI
10.1016/s0959-8049(16)31329-6
Conference proceedings
European Journal of Cancer
ISSN
0959-8049